Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$105,966,291
+$51,462,375 QoQ
Shares Held
558,835
+102.2% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#125
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $2,307,026,460 across 15 Drug Manufacturers - General names. AZN ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,217,590 | $588,737,534 | |
| 2 | LLY |
ELI LILLY & Co
|
344,960 | $413,755,406 | |
| 3 | PFE |
Pfizer Inc
|
16,584,797 | $399,361,911 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,370,439 | $176,101,411 | |
| 5 | JNJ |
Johnson & Johnson
|
644,520 | $163,688,742 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
558,835 | $105,966,291 | |
| 7 | NVS |
Novartis AG
|
633,523 | $99,285,724 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
716,459 | $90,517,428 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,966,291 | 558,835 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $54,503,916 | 276,361 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||